Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
JNJ-0631
i
Other names:
ARX-305, JNJ0631, JNJ 0631, NCB-002, NCB 002, JNJ-0631, ARX305, anti-CD70 ADC, NCB002, ARX 305
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
J&J, Zhejiang Medicine
Drug class:
CD70-targeted antibody-drug conjugate
Related drugs:
‹
SGN-CD70A (1)
AMG 172 (0)
GEN1160 (0)
MDX-1203 (0)
SGN-CD70A (1)
AMG 172 (0)
GEN1160 (0)
MDX-1203 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CD70 expression
Uterine Corpus Leiomyosarcoma
CD70 expression
Uterine Corpus Leiomyosarcoma
JNJ-0631
Sensitive: C3 – Early Trials
JNJ-0631
Sensitive
:
C3
JNJ-0631
Sensitive: C3 – Early Trials
JNJ-0631
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login